Edition:
United States

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

220.31USD
17 Nov 2017
Change (% chg)

$-1.21 (-0.55%)
Prev Close
$221.52
Open
$220.77
Day's High
$221.40
Day's Low
$219.97
Volume
216,650
Avg. Vol
289,618
52-wk High
$225.18
52-wk Low
$161.31

Chart for

About

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $50,410.19
Shares Outstanding(Mil.): 227.57
Dividend: 0.73
Yield (%): 1.32

Financials

  Industry Sector
P/E (TTM): -- 50.87 15.80
EPS (TTM): -- -- --
ROI: -- 13.26 12.07
ROE: -- 19.83 16.02

BRIEF-Merit Medical signs purchase agreement with BD for divestment assets

* Merit Medical signs purchase agreement with BD for divestment assets

Nov 16 2017

BRIEF-Becton Dickinson says Q4 earnings per share $1.24

* BD announces results for 2017 fourth fiscal quarter and full year; provides fiscal 2018 guidance

Nov 02 2017

BRIEF-U.S. court denies motion to reconsider Becton, Dickinson and Co. judgment

* Retractable Technologies Inc says on Oct 27, court denied motion to alter or amend earlier judgment in co's case against Becton, Dickinson and Co​ Source text for Eikon: Further company coverage:

Oct 31 2017

BRIEF-BD announces extension of exchange offers and consent solicitations for C. R. Bard, Inc.

* BD announces extension of exchange offers and consent solicitations for C. R. Bard, Inc. Notes Source text for Eikon: Further company coverage:

Oct 26 2017

BRIEF-BD statement on European Commission conditional clearance of Bard acquisition

* BD statement on European Commission conditional clearance of bard acquisition

Oct 18 2017

EU mergers and takeovers (Oct 18)

BRUSSELS, Oct 18 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Oct 18 2017

Becton Dickinson wins conditional EU approval for $24 billion Bard buy

BRUSSELS U.S. medical equipment supplier Becton Dickinson secured EU antitrust approval for its $24-billion acquisition of U.S. peer C R Bard after it agreed to sell two businesses to allay competition concerns.

Oct 18 2017

Becton Dickinson wins conditional EU approval for $24 bln Bard buy

BRUSSELS, Oct 18 U.S. medical equipment supplier Becton Dickinson secured EU antitrust approval for its $24-billion acquisition of U.S. peer C R Bard after it agreed to sell two businesses to allay competition concerns.

Oct 18 2017

EU mergers and takeovers (Oct 17)

BRUSSELS, Oct 17 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Oct 17 2017

EU mergers and takeovers (Oct 11)

BRUSSELS, Oct 11 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Oct 11 2017

Earnings vs. Estimates